Stocks
Astellas Pharma Inc.ALPMY
OTCHealthcareBiotechnology$14.66-0.74%
Price as of · delayed, not real-time
A global pharmaceutical company focused on developing and commercializing innovative therapies, particularly in oncology, urology, and immunology. With a robust pipeline and strategic partnerships, it is a key player in addressing unmet medical needs, making it a notable stock for healthcare investors.
Market Cap: $26.3B52W Range: $8.37 – $16.95
Congressional Interest in Astellas Pharma Inc. (ALPMY)
6 members of Congress have disclosed 22 trades in Astellas Pharma Inc. (ALPMY), a Healthcare company. The buy/sell breakdown shows 13 purchases versus 9 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
22
Unique Politicians
6
Buys
13
Sells
9
Who in Congress Is Trading ALPMY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $15K – $50K |
| 2023-02-27 | Daniel Goldman | buy | $15K – $50K |
| 2023-01-13 | Daniel Goldman | sell | $1K – $15K |
| 2020-03-18 | Greg Gianforte | buy | $15K – $50K |
| 2018-11-19 | Greg Gianforte | sell | $1K – $15K |
| 2018-08-09 | David P. Roe | buy | $1K – $15K |
| 2018-07-10 | David P. Roe | sell | $1K – $15K |
| 2018-06-01 | David P. Roe | buy | $1K – $15K |
| 2018-03-26 | Greg Gianforte | buy | $1K – $15K |
| 2017-07-31 | David P. Roe | buy | $1K – $15K |
| 2017-05-26 | David P. Roe | buy | $1K – $15K |
| 2017-05-25 | David P. Roe | sell | $15K – $50K |
| 2017-05-10 | Thomas MacArthur | sell | $15K – $50K |
| 2017-01-10 | Thomas MacArthur | buy | $1K – $15K |
| 2017-01-09 | Thomas MacArthur | buy | $15K – $50K |
| 2016-12-07 | Thomas MacArthur | sell | $15K – $50K |
| 2016-09-20 | Thomas MacArthur | buy | $1K – $15K |
| 2016-07-27 | Thomas MacArthur | buy | $1K – $15K |
| 2016-07-26 | Thomas MacArthur | buy | $15K – $50K |
| 2015-03-31 | JAMES B. RENACCI | buy | $1K – $15K |
| 2012-01-10 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2012-01-10 | MICHAEL T. MCCAUL | sell | $1K – $15K |